Intrinsiqq
Bruker Corporation logo

Bruker Corporation Quality Score

BRKR

⊜ Compare
Quality23

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-91.1x

Negative earnings, no valuation support

Cash Flow Multiple
40/100
103.5x

Above 30x, cash flow yield is thin

Revenue Growth
70/100
8.4%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
0/100
-10.3%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
60/100
1.9%

Mild dilution under 2%

Margin Trend
0/100
-13.6pp

Contracted >2pp, margin pressure

Capital Structure
0/100
$1.64B

Net debt/FCF of 17.5x, high leverage

2022
$646M
$1.28B
2023
$488M
$1.40B
2024
$183M
$2.26B
2025
$299M
$2.06B
TTM
$185M
$1.82B
CashDebt
Return on Capital
0/100
1.9%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Bruker (BRKR) quality: score, margins and returns

Bruker (BRKR) scores 23/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 7 metrics each scored 0 to 100, on 3.5% operating margins and 1.9% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Bruker (BRKR) a high-quality business?+

Bruker scores 23 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 3.5% operating margin and a 1.9% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Bruker's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from BRKR's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Bruker scores well and where it falls behind.

What is Bruker's return on invested capital (ROIC)?+

Bruker earns about 1.9% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to BRKR's margins and growth on this scorecard to judge durability.

How profitable is Bruker?+

Bruker runs an operating margin of about 3.5% and a net margin of about -2.0%. Revenue has grown at roughly 11.6% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 5 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with BRKR

CompareIntrinsic value
RVTYRevvity Inc.
$159.44-2.47%20
MTDMettler-Toledo International Inc.
$1,723.24+1.48%41
BIOBio-Rad Laboratories Inc.
$379.99+1.35%48
ILMNIllumina, Inc.
$226.54-4.90%68
WATWaters Corporation
$467.60+1.67%25
TXG10x Genomics Inc.
$67.52+3.42%48
AVTRAvantor Inc.
$15.65+0.38%22
AAgilent Technologies Inc.
$177.17+0.97%44

Held by ETFs

BRKR is in 113 US ETFs. The largest of them, with BRKR's weight in each:

Spot a number that looks wrong? Check it in BRKR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BRKR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.